Acorah Software Products - Accounts Production 16.0.110 false true 31 March 2023 1 April 2022 false 1 April 2023 31 March 2024 31 March 2024 10661831 Miss Nena Klimenta iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10661831 2023-03-31 10661831 2024-03-31 10661831 2023-04-01 2024-03-31 10661831 frs-core:CurrentFinancialInstruments 2024-03-31 10661831 frs-core:PlantMachinery 2024-03-31 10661831 frs-core:PlantMachinery 2023-04-01 2024-03-31 10661831 frs-core:PlantMachinery 2023-03-31 10661831 frs-core:ShareCapital 2024-03-31 10661831 frs-core:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 10661831 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 10661831 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10661831 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 10661831 frs-bus:SmallEntities 2023-04-01 2024-03-31 10661831 frs-bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 10661831 frs-bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 10661831 frs-bus:Director1 2023-04-01 2024-03-31 10661831 frs-countries:EnglandWales 2023-04-01 2024-03-31 10661831 2022-03-31 10661831 2023-03-31 10661831 2022-04-01 2023-03-31 10661831 frs-core:CurrentFinancialInstruments 2023-03-31 10661831 frs-core:ShareCapital 2022-03-31 10661831 frs-core:ShareCapital 2023-03-31 10661831 frs-core:RetainedEarningsAccumulatedLosses 2022-04-01 2023-03-31 10661831 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2022-03-31 10661831 frs-core:RetainedEarningsAccumulatedLosses 2023-03-31
Registered number: 10661831
THE IVY CLINIC LTD
Unaudited Financial Statements
For The Year Ended 31 March 2024
ZA LTD
FMAAT AND FFA
Contents
Page
Accountants' Report 1
Balance Sheet 2—3
Statement of Changes in Equity 4
Notes to the Financial Statements 5—6
Page 1
Accountants' Report
Report of the Accountant to the director of THE IVY CLINIC LTD
These financial statements have been prepared in accordance with our terms of engagement and in order to assist you to fulfil your duties under the Companies Acts that relate to preparing the financial statements of the company for the year ended 31 March 2024.
We have prepared these financial statements based on the accounting records, information and explanations provided by you. We do not express any opinion on the financial statements.
On the Balance Sheet you have acknowledged your duties under the prevailing Companies Acts to ensure that the company keeps adequate accounting records and prepares financial statements that give “a true and fair view”.
You have determined that the company is exempt from the statutory requirement for an audit for this accounting year. Therefore, the financial statements are unaudited.
The financial statements are provided exclusively to the director for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.
Signed
ZA Ltd
13/10/2024
ZA LTD
FMAAT AND FFA
Page 1
Page 2
Balance Sheet
Registered number: 10661831
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 17,037 21,951
17,037 21,951
CURRENT ASSETS
Debtors 5 40 -
Cash at bank and in hand 1,323 885
1,363 885
Creditors: Amounts Falling Due Within One Year 6 (4,952 ) (7,020 )
NET CURRENT ASSETS (LIABILITIES) (3,589 ) (6,135 )
TOTAL ASSETS LESS CURRENT LIABILITIES 13,448 15,816
NET ASSETS 13,448 15,816
CAPITAL AND RESERVES
Called up share capital 7 1 1
Profit and Loss Account 13,447 15,815
SHAREHOLDERS' FUNDS 13,448 15,816
Page 2
Page 3
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Miss Nena Klimenta
Director
13/10/2024
The notes on pages 5 to 6 form part of these financial statements.
Page 3
Page 4
Statement of Changes in Equity
Share Capital Profit and Loss Account Total
£ £ £
As at 1 April 2022 1 7,808 7,809
Profit for the year and total comprehensive income - 20,007 20,007
Dividends paid - (12,000) (12,000)
As at 31 March 2023 and 1 April 2023 1 15,815 15,816
Profit for the year and total comprehensive income - 14,632 14,632
Dividends paid - (17,000) (17,000)
As at 31 March 2024 1 13,447 13,448
Page 4
Page 5
Notes to the Financial Statements
1. General Information
THE IVY CLINIC LTD is a private company, limited by shares, incorporated in England & Wales, registered number 10661831 . The registered office is 60 Barlby Road, London, W10 6AP.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts. Turnover includes revenue earned from the from the rendering of services.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 25% on reducing balance method
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was:
2024 2023
Office and administration 1 1
1 1
Page 5
Page 6
4. Tangible Assets
Plant & Machinery
£
Cost
As at 1 April 2023 46,068
Additions 765
As at 31 March 2024 46,833
Depreciation
As at 1 April 2023 24,117
Provided during the period 5,679
As at 31 March 2024 29,796
Net Book Value
As at 31 March 2024 17,037
As at 1 April 2023 21,951
5. Debtors
2024 2023
£ £
Due within one year
Prepayments and accrued income 40 -
6. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Corporation tax 4,252 4,319
Accruals and deferred income 700 701
Director's loan account - 2,000
4,952 7,020
7. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 1 1
8. Dividends
2024 2023
£ £
On equity shares:
Final dividend paid 17,000 12,000
Page 6